Ariel G. Labrada-Ramirez
Madrid, MD 28029, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Mutant calreticulin enables potent and selective CAR-T cell therapy in preclinical models of myeloproliferative neoplasms.
Journal: Journal for immunotherapy of cancer
Published: November 25, 2025
Expansion and activation of NK cells supported by accessory cells. Phenotypic and functional characterization.
Journal: Methods in cell biology
Published: July 19, 2025
Peripheral Blood TCRβ Repertoire, IL15, IL2 and Soluble Ligands for NKG2D Activating Receptor Predict Efficacy of Immune Checkpoint Inhibitors in Lung Cancer.
Journal: Cancers
Published: June 27, 2024
Biomarkers of Immunotherapy Response in Patients with Non-Small-Cell Lung Cancer: Microbiota Composition, Short-Chain Fatty Acids, and Intestinal Permeability.
Journal: Cancers
Published: February 17, 2024
Selective Detection of Active Extracellular Granzyme A by Using a Novel Fluorescent Immunoprobe with Application to Inflammatory Diseases.
Journal: ACS pharmacology & translational science
Published: February 07, 2024
Multiparametric in vitro and in vivo analysis of the safety profile of self-assembling peptides.
Journal: Scientific reports
Published: October 25, 2023
CAR Immunotherapy for the treatment of infectious diseases: a systematic review.
Journal: Frontiers in immunology
Published: September 05, 2023
A Subset of PD-1-Expressing CD56bright NK Cells Identifies Patients with Good Response to Immune Checkpoint Inhibitors in Lung Cancer.
Journal: Cancers
Published: December 02, 2022
PD-1 is expressed in cytotoxic granules of NK cells and rapidly mobilized to the cell membrane following recognition of tumor cells.
Journal: Oncoimmunology
Published: July 11, 2022
Last Updated: 09/26/2026